跳至主要内容
临床试验/NCT04218591
NCT04218591已完成不适用

A Study on the Effect of Platelet Rich Plasma (PRP) on Osteoarthritis in the Thumb Base

Karolinska Institutet1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2020年2月24日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
90
试验地点
1
主要终点
Change in patient-rated pain on load

研究概览

简要总结

Randomized comparison between Platelet Rich Plasma (PRP) and placebo (Saline) for thumb base.osteoarthritis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

性别
All
接受健康志愿者
否

入选标准

  • •Arthritis in the thumb base.
  • •Radiological Eaton Littler class 1-
  • •Clinical signs of thumb base osteoarthritis: pain at palpation of the CMC-1 joint and pain during provocation/grinding test.

排除标准

  • •Rheumatoid arthritis.
  • •Ongoing infection in the hand or wrist.
  • •History of gout or pseudo gout.
  • •Inability to co-operate with the follow-up protocol (language difficulties, severe psychiatric disorder, cognitive impairment, drug addiction).
  • •Intra-articular injection in the affected joint within 6 months.
  • •Eaton Littler class 4 (STT joint involved).

研究组 & 干预措施

Saline

Placebo Comparator

Intra-articular injection Saline

干预措施: Placebo (Other)

PRP

Active Comparator

Intra-articular injection PRP

干预措施: PRP (Other)

结局指标

主要结局

Change in patient-rated pain on load

时间窗: 3 and 6 months after injection.

Numerical rating scale 0-10p (10=worst possible pain).

次要结局

  • Change in Nelson Thumb score(3 and 6 months after injection.)
  • Change in Patient-rated Wrist and Hand Evaluation (PRWHE)(3 and 6 months after injection.)
  • Change in thumb strength(3 and 6 months after injection.)
  • Change in EQ-5D(3 and 6 months after injection.)
  • Change in Disability of the Hand, Arm and Shoulder (DASH) score(3 and 6 months after injection.)
  • Change in Pain Catastrophizing Score (PCS).(3 and 6 months after injection.)
  • Change in Hospital Anxiety and Depression Score (HADS),(3 and 6 months after injection.)
  • Change in thumb range of motion(3 and 6 months after injection.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Maria Wilcke

Principal Investigator

Karolinska Institutet

研究点 (1)

Loading locations...

相似试验